Literature DB >> 16393432

A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.

Antonio Martínez1, Manuel Sánchez.   

Abstract

OBJECTIVE: To assess the effects of dorzolamide/timolol fixed combination (DTFC) and latanoprost 0.005% on the retrobulbar haemodynamics and intraocular pressure (IOP) of open-angle glaucoma patients.
METHODS: 22 consecutive subjects with newly diagnosed, open-angle glaucoma were included in this prospective, examiner masked, randomized, crossover study. The patients were randomized into two different arms. Peak systolic velocity (PSV), end-diastolic velocity (EDV), Pourcelot's resistance index (RI) and intraocular pressure (IOP) were determined at baseline and after 1 month of medical treatment with DTFC or latanoprost 0.005% in both groups. A 4-week washout period, without medical treatment, between study arms was carried out. Primary efficacy variables were the PSV, EDV and RI in the ophthalmic artery (OA) and short posterior ciliary artery (SPCA) and intraocular pressure (IOP). Inter- and intra-group comparisons were performed with a one-way ANOVA test and two-tailed paired Student's t-test respectively.
RESULTS: Intraocular pressure (IOP) and colour Doppler imaging (CDI) measurements were similar at baseline. Compared to baseline and washout measurements, only the fixed combination dorzolamide/timolol significantly increased the EDV in the OA and in the SPCA, p = 0.00012 and p = 0.00012, respectively and decreased the resistance index in the ophthalmic and short posterior ciliary arteries, p = 0.00011 and p = 0.00031, respectively. There were no statistically significant differences in the IOP lowering effect of either treatment.
CONCLUSION: Over a treatment period of 1 month, only the fixed combination dorzolamide/timolol seems to have a vascular effect on retrobulbar vessels. Further research is necessary to confirm these results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16393432     DOI: 10.1185/030079906X80215

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  10 in total

1.  Retrobulbar hemodynamic parameters in open-angle and angle-closure glaucoma patients.

Authors:  I Marjanovic; N Milic; A Martinez; J Benitez-del-Castillo
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

Review 2.  Topical dorzolamide 2%/timolol 0.5% ophthalmic solution: a review of its use in the treatment of glaucoma and ocular hypertension.

Authors:  James E Frampton; Caroline M Perry
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 3.  Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?

Authors:  Ari Stoner; Alon Harris; Francesco Oddone; Aditya Belamkar; Alice Chandra Verticchio Vercellin; Joshua Shin; Ingrida Januleviciene; Brent Siesky
Journal:  Br J Ophthalmol       Date:  2021-08-25       Impact factor: 5.908

4.  Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients.

Authors:  Adam M Moss; Alon Harris; Brent Siesky; Deepam Rusia; Kathleen M Williamson; Yochai Shoshani
Journal:  Clin Ophthalmol       Date:  2010-04-26

5.  Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2010-07-30

6.  Retrobulbar hemodynamic parameters in pseudoexfoliation syndrome and pseudoexfoliative glaucoma.

Authors:  Antonio Martinez; Manuel Sanchez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-20       Impact factor: 3.117

7.  A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar hemodynamics and intraocular pressure in open-angle glaucoma patients.

Authors:  Antonio Martínez; Manuel Sánchez-Salorio
Journal:  J Ocul Pharmacol Ther       Date:  2009-06       Impact factor: 2.671

8.  Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension.

Authors:  Parul Ichhpujani; L Jay Katz
Journal:  Drug Healthc Patient Saf       Date:  2010-05-24

9.  Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension.

Authors:  Henny J M Beckers; Jan Sag Schouten; Carroll A B Webers
Journal:  Clin Ophthalmol       Date:  2009-11-02

10.  Influence of latanoprost on retinal microcirculation in glaucoma.

Authors:  S Kremmer; M Iliadou; G Anastassiou; M Schallenberg; W Vilser; K P Steuhl; J M Selbach
Journal:  Open Ophthalmol J       Date:  2014-10-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.